Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director | December 04, 2020 | December 08, 2020 |
| GENERAL DYNAMICS CORPGD · Entity 2916 | Director · Chairman and CEO | July 31, 2026 | August 04, 2026 |
| JPMORGAN CHASE & COJPM · Entity 2795 | Director | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 04, 2020 · Filed December 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 41,004 |
Ending reported balance
After 2020-12-04 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-12-04 · Exercise / conversion · Acquired 3,333 · Balance 34,446 Row 2 · 2020-12-04 · Exercise / conversion · Acquired 11,348 · Balance 45,794 Row 3 · 2020-12-04 · Sale · Disposed 4,790 · Balance 41,004 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.275 to $107.285, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.84 · Expires 2022-04-26 | Direct | 0 |
Reported balance
After 2020-12-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-12-04 · Exercise / conversion · Disposed 3,333 · Balance 0 F2: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.48 · Expires 2023-04-25 | Direct | 0 |
Reported balance
After 2020-12-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-12-04 · Exercise / conversion · Disposed 11,348 · Balance 0 F2: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.275 to $107.285, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
GENERAL DYNAMICS CORP
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 766,457 |
Ending reported balance
After 2026-08-03 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-07-31 · Exercise / conversion · Acquired 166,660 · Balance 933,117 Row 2 · 2026-07-31 · Tax withholding · Disposed 115,092 · Balance 818,025 Row 3 · 2026-08-03 · Sale · Disposed 5,673 · Balance 812,352 F1: Sale prices ranged from $380.575 to $381.56. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price. Row 4 · 2026-08-03 · Sale · Disposed 22,707 · Balance 789,645 F2: Sale prices ranged from $381.575 to $382.56. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price. Row 5 · 2026-08-03 · Sale · Disposed 15,917 · Balance 773,728 F3: Sale prices ranged from $382.58 to $383.575. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price. Row 6 · 2026-08-03 · Sale · Disposed 7,271 · Balance 766,457 F4: Sale prices ranged from $383.62 to $384.07. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $165.47 · Expires 2030-03-03 | Direct | 0 |
Reported balance
After 2026-07-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-07-31 · Exercise / conversion · Disposed 166,660 · Balance 0 F7: Fifty percent became exercisable on 03/04/2022, and the remaining fifty percent became exercisable on 03/04/2023. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 5,926.943 |
Reported balance
Holding disclosure · report date 2026-07-31 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 5,926.943 F5: Includes share activity under General Dynamics 401(k) plan since date of Reporting Person's last ownership report. |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 30,000 |
Reported balance
Holding disclosure · report date 2026-07-31 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 30,000 F6: Represents shares held by a limited liability company for which the Reporting Person serves as a manager and the members of which are trusts for the benefit of the Reporting Person's children. |
Filing footnotes · ownership attribution and instrument terms
F1: Sale prices ranged from $380.575 to $381.56. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price.
F2: Sale prices ranged from $381.575 to $382.56. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price.
F3: Sale prices ranged from $382.58 to $383.575. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price.
F4: Sale prices ranged from $383.62 to $384.07. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price.
F5: Includes share activity under General Dynamics 401(k) plan since date of Reporting Person's last ownership report.
F6: Represents shares held by a limited liability company for which the Reporting Person serves as a manager and the members of which are trusts for the benefit of the Reporting Person's children.
F7: Fifty percent became exercisable on 03/04/2022, and the remaining fifty percent became exercisable on 03/04/2023.
JPMORGAN CHASE & CO
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,761.5744 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 120.908 · Balance 13,761.5744 F1: Deferral of quarterly retainer, payable in common stock following termination of service as director. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 45 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 45 |
Filing footnotes · ownership attribution and instrument terms
F1: Deferral of quarterly retainer, payable in common stock following termination of service as director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2020 Filed Dec 8, 2020 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,333 | $0.00 Strike: $29.84 | $0.00 |
DisclosureSEC source: 0001415889-20-002858 · form4-12082020_021215.xml · derivative · entry 4 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,333 shares Expires 2022-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,790 | $107.28 | $513,849.17 |
DisclosureSEC source: 0001415889-20-002858 · form4-12082020_021215.xml · nonDerivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,004 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.275 to $107.285, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 11,348 | $36.48 | $413,975.04 |
DisclosureSEC source: 0001415889-20-002858 · form4-12082020_021215.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,333 | $29.84 | $99,456.05 |
DisclosureSEC source: 0001415889-20-002858 · form4-12082020_021215.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2020 Filed Sep 17, 2020 19:05 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050849 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,565 Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 21:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,739 | $0.00 Strike: $25.05 | $0.00 |
DisclosureSEC source: 0001179110-20-008493 · edgar.xml · derivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,739 shares Expires 2021-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 21:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 933 | $100.78 | $94,025.87 |
DisclosureSEC source: 0001179110-20-008493 · edgar.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,113 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.7601 to $100.781, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 21:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,739 | $25.05 | $93,676.53 |
DisclosureSEC source: 0001179110-20-008493 · edgar.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 21:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 9,030 | $0.00 Strike: $93.68 | $0.00 |
DisclosureSEC source: 0001179110-20-005186 · edgar.xml · derivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,030 Underlying: Common shares · 9,030 shares Expires 2030-04-23 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 21:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005186 · edgar.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,307 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 19:58 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 166,660 | $0.00 Strike: $165.47 | $0.00 |
DisclosureSEC source: 0001209191-20-016538 · doc4.xml · derivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,660 Underlying: Common Stock · 166,660 shares Expires 2030-03-03 F3 · derivative.exercise_date: Fifty percent become exercisable on 03/04/2022 and the remaining fifty percent become exercisable on 03/04/2023. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 19:58 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 16,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016538 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,565 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 21:25 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 12,924 | $165.46 | $2,138,405.04 |
DisclosureSEC source: 0001209191-20-016082 · doc4.xml · nonDerivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 707,885 F3 · kind: Withholding of shares of Common Stock under General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations on release of PSUs. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 21:25 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 28,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016082 · doc4.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720,809 F2 · kind: Represents performance stock units (PSUs) originally granted in 2017. Includes additional units issued upon achievement of the performance criteria, as well as accrued dividend equivalents. No further service-based vesting is required. The PSUs and dividend equivalents are settled in shares of common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 8,234 | $161.42 | $1,329,132.28 |
DisclosureSEC source: 0001209191-20-016082 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,154 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 20:27 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 11,789 | $177.98 | $2,098,206.22 |
DisclosureSEC source: 0001209191-20-001661 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,388 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:02 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 466,380 | $0.00 Strike: $112.40 | $0.00 |
DisclosureSEC source: 0001209191-19-056705 · doc4.xml · derivative · entry 4 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 466,380 shares Expires 2021-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fifty percent became exercisable on 03/05/2015 and the remaining fifty percent became exercisable on 03/05/2016. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:02 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 389,921 | $184.65 | $71,996,963.05 |
DisclosureSEC source: 0001209191-19-056705 · doc4.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,177 Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:02 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 466,380 | $112.40 | $52,421,112.00 |
DisclosureSEC source: 0001209191-19-056705 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:17 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 733,000 | $0.00 Strike: $67.70 | $0.00 |
DisclosureSEC source: 0001209191-19-038909 · doc4.xml · derivative · entry 5 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 733,000 shares Expires 2020-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fifty percent became exercisable on 03/06/2014 and the remaining fifty percent became exercisable on 03/06/2015. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:17 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 271,605 | $177.20 | $48,128,406.00 |
DisclosureSEC source: 0001209191-19-038909 · doc4.xml · nonDerivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,718 Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:17 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 271,562 | $177.33 | $48,156,089.46 |
DisclosureSEC source: 0001209191-19-038909 · doc4.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907,323 Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:17 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 733,000 | $67.70 | $49,624,100.00 |
DisclosureSEC source: 0001209191-19-038909 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,178,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 10,837 | $0.00 Strike: $78.06 | $0.00 |
DisclosureSEC source: 0001179110-19-005301 · edgar.xml · derivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,837 Underlying: Common shares · 10,837 shares Expires 2029-04-25 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005301 · edgar.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,333 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 20:43 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 129,090 | $0.00 Strike: $167.61 | $0.00 |
DisclosureSEC source: 0001209191-19-017718 · doc4.xml · derivative · entry 5 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,090 Underlying: Common Stock · 129,090 shares Expires 2029-03-05 F5 · derivative.exercise_date: Fifty percent become exercisable on 03/06/2021 and the remaining fifty percent become exercisable on 03/06/2022. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 20:43 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 14,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017718 · doc4.xml · nonDerivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,885 F3 · shares: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 20:43 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 18,636 | $167.57 | $3,122,834.52 |
DisclosureSEC source: 0001209191-19-017718 · doc4.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,985 F2 · shares: Withholding of shares of Common Stock under General Dynamics Corporation 2012 Equity Compensation Plan to satisfy tax withholding obligations on release of PRSUs. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 20:43 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 41,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017718 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,621 F1 · shares: Represents performance restricted stock units (PRSUs) originally granted in 2016. Includes additional units issued upon achievement of the performance criteria, as well as accrued dividend equivalents. No further service-based vesting is required. The PRSUs and dividend equivalents are settled in shares of common stock. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 19:40 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 11,346 | $155.64 | $1,765,891.44 |
DisclosureSEC source: 0001209191-19-001831 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,301 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| April 27, 2018 Filed May 1, 2018 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 14,237 | $0.00 Strike: $59.42 | $0.00 |
DisclosureSEC source: 0001179110-18-006027 · edgar.xml · derivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,237 Underlying: Common shares · 14,237 shares Expires 2028-04-26 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 27, 2018 Filed May 1, 2018 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006027 · edgar.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,092 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 186,460 | $0.00 Strike: $223.93 | $0.00 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · derivative · entry 11 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,460 Underlying: Common Stock · 186,460 shares Expires 2028-03-06 F7 · derivative.exercise_date: Fifty percent become exercisable on 03/07/2020 and the remaining fifty percent become exercisable on 03/07/2021. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 39,500 | $0.00 Strike: $67.90 | $0.00 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · derivative · entry 10 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,500 shares Expires 2019-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fifty percent became exercisable 05/02/2013 and the remaining fifty percent became exercisable 05/02/2014. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 14,720 | $0.00 Strike: $71.01 | $0.00 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · derivative · entry 9 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,720 shares Expires 2019-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fifty percent became exercisable on 03/07/2013 and the remaining fifty percent became exercisable on 03/07/2014. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 15,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 7 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,647 F3 · shares: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 25,173 | $225.45 | $5,675,252.85 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 6 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,017 Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 39,500 | $67.90 | $2,682,050.00 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 5 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 9,485 | $225.42 | $2,138,108.70 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 4 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,690 Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 14,720 | $71.01 | $1,045,267.20 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 17,921 | $223.93 | $4,013,049.53 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,455 F2 · shares: Withholding of shares of Common Stock under General Dynamics Corporation 2012 Equity Compensation Plan to satisfy tax withholding obligations on release of PRSUs. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 20:55 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 39,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017980 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,376 F1 · shares: Represents performance restricted stock units (PRSUs) originally granted in 2015. Includes additional units issued upon achievement of the performance criteria, as well as accrued dividend equivalents. No further service-based vesting is required. The PRSUs and dividend equivalents are settled in shares of common stock. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 15:53 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 39,720 | $201.99 | $8,023,042.80 |
DisclosureSEC source: 0001209191-18-002314 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,640 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares and performance restricted stock units. F2 · balance_after: Pursuant to the applicable grant agreement, fractional shares accrued on performance restricted stock units are not issued upon release of the units. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 22:13 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 247.802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-060657 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,360.021 F1 · shares: Represents accrued dividend equivalents on previously earned PRSUs. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:17 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 248.181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048915 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,112.219 F1 · shares: Represents accrued dividend equivalents on previously earned PRSUs. Read SEC document |
| May 05, 2017 Filed May 9, 2017 18:17 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 251.803 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030838 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,864.038 F1 · shares: Represents accrued dividend equivalents on previously earned PRSUs. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 19,385 | $0.00 Strike: $43.64 | $0.00 |
DisclosureSEC source: 0001179110-17-006407 · edgar.xml · derivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,385 Underlying: Common shares · 19,385 shares Expires 2027-04-27 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006407 · edgar.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,147 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 20:38 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 211,620 | $0.00 Strike: $191.71 | $0.00 |
DisclosureSEC source: 0001209191-17-017336 · doc4.xml · derivative · entry 3 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,620 Underlying: Common Stock · 211,620 shares Expires 2027-02-28 F3 · derivative.exercise_date: Fifty percent become exercisable on 03/01/2019 and the remaining fifty percent become exercisable on 03/01/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 20:38 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock, $1.00 par value | 18,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017336 · doc4.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,612.235 F1 · shares: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.